JPH01307438A - Safe lipid composition having high surface activity - Google Patents
Safe lipid composition having high surface activityInfo
- Publication number
- JPH01307438A JPH01307438A JP63138151A JP13815188A JPH01307438A JP H01307438 A JPH01307438 A JP H01307438A JP 63138151 A JP63138151 A JP 63138151A JP 13815188 A JP13815188 A JP 13815188A JP H01307438 A JPH01307438 A JP H01307438A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- acid
- fatty acid
- present
- bile acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 32
- 150000002632 lipids Chemical class 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title claims description 83
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 30
- 229930195729 fatty acid Natural products 0.000 claims abstract description 30
- 239000000194 fatty acid Substances 0.000 claims abstract description 30
- 239000003613 bile acid Substances 0.000 claims abstract description 24
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 22
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 claims abstract description 18
- 150000001447 alkali salts Chemical class 0.000 claims abstract description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 18
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 239000000470 constituent Substances 0.000 claims description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract description 15
- 230000035699 permeability Effects 0.000 abstract description 5
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 244000299461 Theobroma cacao Species 0.000 description 18
- 235000009470 Theobroma cacao Nutrition 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 239000004094 surface-active agent Substances 0.000 description 16
- -1 synthetic glycerin fatty acid Chemical class 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 230000007480 spreading Effects 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 8
- 230000035515 penetration Effects 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 7
- 230000000149 penetrating effect Effects 0.000 description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 239000005642 Oleic acid Substances 0.000 description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- 235000021313 oleic acid Nutrition 0.000 description 6
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 6
- 238000009736 wetting Methods 0.000 description 6
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 4
- 239000008347 soybean phospholipid Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 235000021319 Palmitoleic acid Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000002327 glycerophospholipids Chemical class 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000010215 titanium dioxide Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010007979 Glycocholic Acid Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 229940093761 bile salts Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 229940068998 egg yolk phospholipid Drugs 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 2
- 229940099347 glycocholic acid Drugs 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- KHICUSAUSRBPJT-UHFFFAOYSA-N 2-(2-octadecanoyloxypropanoyloxy)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C(O)=O KHICUSAUSRBPJT-UHFFFAOYSA-N 0.000 description 1
- RNMDNPCBIKJCQP-UHFFFAOYSA-N 5-nonyl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-ol Chemical compound C(CCCCCCCC)C1=C2C(=C(C=C1)O)O2 RNMDNPCBIKJCQP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003858 bile acid conjugate Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000010935 mono and diglycerides of fatty acids Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003443 succinic acid derivatives Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/14—Derivatives of phosphoric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/017—Mixtures of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、掻めて安全性が高く、かつ高度の浸透性、湿
潤性及び展着性等の界面活性作用を有する脂質系の組成
物に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention provides a lipid-based composition that is extremely safe and has surfactant effects such as high permeability, wettability, and spreadability. Regarding.
(従来の技術及び発明が解決しようとする課題〕現在、
食品、飼料、化粧品、トイレタリー製品、医薬品及び農
薬等の分野で用いられる安全性の高い界面活性剤として
は、グリセロ燐脂質(レシチン)及びその分別物、水素
添加物又は部分的な酵素処理物や、天然又は合成された
、グリセリン脂肪酸モノエステル、ソルビタン脂肪酸エ
ステル、蔗糖脂肪酸エステル、プロピレングリコール脂
肪酸エステル、ポリグリセリン脂肪酸エステル、グリセ
リン脂肪酸モノエステルの酒石酸、リンゴ酸、酢酸、乳
酸、コハク酸の誘導体、ポリグリセリン縮合リシルン酸
エステル、脂肪酸塩、ステアロイル−2−ラクチル酸塩
、ポリオキシエチレンソルビタン脂肪酸エステル、ポリ
オキシエチレン脂肪酸エステル、ジオクチルスルフォコ
ハク酸ナトリウム、ドデシル硫酸ナトリウム、モノ及び
アシルフォスファチジン酸塩等が挙げられ、これらの界
面活性剤は比較的安全性の高いものとして各国で用いら
れている。しかし、グリセロ燐脂f1(レシチン)と脂
肪酸のモノ及びジグリセリド以−9tの界面活性剤は、
1日当たりの許容摂取量が定められ、また使用対象物も
制限されているものが多く、無制限な使用が認められて
いないのが各国の実態である。(Problems to be solved by conventional techniques and inventions) Currently,
Highly safe surfactants used in the fields of food, feed, cosmetics, toiletry products, pharmaceuticals, and agricultural chemicals include glycerophospholipids (lecithin) and their fractions, hydrogenated products, partially enzyme-treated products, and , natural or synthetic glycerin fatty acid monoester, sorbitan fatty acid ester, sucrose fatty acid ester, propylene glycol fatty acid ester, polyglycerin fatty acid ester, tartaric acid, malic acid, acetic acid, lactic acid, succinic acid derivatives of glycerin fatty acid monoester, poly Glycerin condensed lysylinate, fatty acid salt, stearoyl-2-lactylate, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene fatty acid ester, sodium dioctyl sulfosuccinate, sodium dodecyl sulfate, mono- and acylphosphatidate, etc. These surfactants are considered to be relatively safe and are used in various countries. However, surfactants containing glycerophospholipid f1 (lecithin) and mono- and diglycerides of fatty acids,
The reality in each country is that the permissible intake per day is determined, and the substances that can be used are often restricted, and unlimited use is not permitted.
また、大豆燐脂質(レシチン)をフォスフォリバーゼA
で処理して得られるモノアシルグリセロ燐脂質、特にリ
ゾフォスファチジルコリンや、高純度の蔗糖モノ脂肪酸
エステル等は、安全で優れた界面活性能を有するが、こ
れらの界面活性剤は、浸透、湿潤及び展着などの作用を
十分に有するとはいえない。In addition, soybean phospholipids (lecithin) can be treated with phospholibase A.
Monoacylglycerophospholipids, especially lysophosphatidylcholine, and highly purified sucrose monofatty acid esters obtained by treatment with It cannot be said that it has sufficient effects such as wetting and spreading.
また、特公昭59−51241号公報、米国特許第3,
388,999号明細書、デンマーク特許第101,6
49号明細書、米国特許第3,661.795号明細書
及び同第3,549.382号明細書には、界面活性作
用を有する種々の組成物が記載されているが、いずれの
組成物も効果が不十分なものである。Also, Japanese Patent Publication No. 59-51241, U.S. Patent No. 3,
No. 388,999, Danish Patent No. 101,6
No. 49, U.S. Pat. No. 3,661.795 and U.S. Pat. No. 3,549.382 describe various compositions having surfactant action, but none of the compositions The effect is also insufficient.
また、公表特許公報昭62−502891号には、(a
)少なくとも1種類の炭素数14〜18の脂肪酸、Φ)
グリセリンと炭素数14〜18の脂肪酸の少なくとも1
種類のモノグリセド、(C)炭素数14〜18の脂肪酸
成分を含むリゾフォスファチジルコリン、及び任意成分
としテ(d)薬物を含む、経口投与した物質の体内への
吸収を促進するための組成物が記載されている。そして
、上記公表特許公報には、上記成分(a)、(ロ)及び
(C)を構成する脂肪酸として、パルミトレイン酸、オ
レイン酸、リノール酸、リルン酸及び炭素数14〜18
の飽和脂肪酸が記載されている。In addition, in published patent publication No. 1982-502891, (a
) At least one type of fatty acid having 14 to 18 carbon atoms, Φ)
At least one of glycerin and a fatty acid having 14 to 18 carbon atoms
(C) lysophosphatidylcholine containing a fatty acid component having 14 to 18 carbon atoms; and (d) a drug as an optional component, for promoting the absorption into the body of an orally administered substance. things are listed. The above-mentioned published patent publication describes palmitoleic acid, oleic acid, linoleic acid, lylunic acid, and carbon atoms 14 to 18 as the fatty acids constituting the components (a), (b), and (C).
of saturated fatty acids are listed.
しかし、上記公表特許公報に記載の組成物は、経口投与
した物質を分配するための組成物であって、界面活性を
得ることが主たる目的ではない。However, the composition described in the above-mentioned published patent publication is a composition for dispensing an orally administered substance, and its main purpose is not to obtain surface activity.
従って、上記公表特許公報に記載の組成物の範囲では十
分に強い活性が得られない0例えば、上記公表特許公報
に記載の組成物の(a)成分に含まれる炭素数14〜1
8の飽和脂肪酸を用いた組成物は、浸透力、湿潤力及び
展着性などの界面活性が極めて不良である。Therefore, sufficiently strong activity cannot be obtained within the range of the composition described in the above-mentioned published patent publication.
The composition using saturated fatty acid No. 8 has extremely poor surface activities such as penetrating power, wetting power, and spreading property.
従って、本発明の目的は、極めて安全性が高く、かつ高
度の浸透性、湿潤性及び展着性等の界面活性作用を有す
る脂質系の組成物を提供することにある。Therefore, an object of the present invention is to provide a lipid-based composition that is extremely safe and has surfactant effects such as high permeability, wettability, and spreadability.
本発明者は、種々検討した結果、フォスフオリパーゼ入
−2によって部分分解されたグリセロ燐脂質と不飽和脂
肪酸のモノグリセリド及び/又は中鎖脂肪酸のモノグリ
セリドとからなる組成物が、安全性が高く、かつ強力な
界面活性作用を有し、しかも安価に得ることができるこ
とを知見し、これらの組成物について先に出願を行った
(特願昭62−207093号及び同62−24020
5号)、シかし、これらの組成物は、浸透作用及び展着
作用において必ずしも十分でなかった。As a result of various studies, the present inventor found that a composition consisting of a glycerophospholipid partially decomposed by phospholipase-2 and a monoglyceride of an unsaturated fatty acid and/or a monoglyceride of a medium-chain fatty acid is highly safe. They found that these compositions had a strong surfactant effect and could be obtained at low cost, and filed applications for these compositions (Japanese Patent Application Nos. 62-207093 and 62-24020).
No. 5), but these compositions were not necessarily sufficient in penetration and spreading effects.
本発明者は、更に種々検討した結果、下記の脂質組成物
が本発明の前記目的を達成するものであることを見出し
、本発明に到達した。As a result of further various studies, the present inventors discovered that the following lipid composition achieves the above object of the present invention, and arrived at the present invention.
即ち、本発明は、下記の脂質組成物を提供するものであ
る。That is, the present invention provides the following lipid composition.
必須の構成成分として、
■リゾフォスファチジルコリン、
■炭素原子数16〜22の不飽和脂肪酸のモノグリセリ
ド、及び
■炭素原子数9〜13の脂肪酸を含有し、上記成分■〜
■の割合(重量比)は、
■/■=10/90〜90/10
■/■=20/100〜200/100■/(■+■)
=10/100〜200/100であり、かつ
(■+■)/■が5を超える場合は、
■胆汁酸類及び/又は胆汁酸のアルカリ塩類を、成分(
■+■+■)の重量の5〜100%含有する
ことを特徴とする安全でかつ高度な界面活性を有する脂
質組成物。Contains as essential constituents, ■ lysophosphatidylcholine, ■ monoglycerides of unsaturated fatty acids having 16 to 22 carbon atoms, and ■ fatty acids having 9 to 13 carbon atoms, and contains the above components ■ ~
The ratio (weight ratio) of ■ is: ■/■=10/90 to 90/10 ■/■=20/100 to 200/100■/(■+■)
= 10/100 to 200/100 and (■+■)/■ exceeds 5, ■bile acids and/or alkali salts of bile acids are added to the component (
1. A lipid composition that is safe and has a high degree of surface activity, characterized in that it contains 5 to 100% of the weight of
以下、本発明の安全でかつ高度な界面活性を有する脂質
組成物について詳述する。The safe and highly surface-active lipid composition of the present invention will be described in detail below.
本発明の組成物の必須の構成成分の一つである■リゾフ
ォスファチジルコリンは、例えば大豆燐脂質、ナタネ燐
脂質、コーン胚燐脂質、卵黄燐脂質などの天然物から、
フォスフオリバーゼA−2又はフォスフォリバーゼA−
2によって部分加水分解を行ってリゾ燐脂質となし更に
分解生成物を溶媒による分別やカラムクロマトグラフィ
ーなどの手段によって分別したものが用いられる。また
、化学的に合成されたもの、或いは各種のフオスフォリ
パーゼ(A、 B、 C,D)を用いて、生物学的にエ
ステル交換反応を行って造られた任意のコリンフォスフ
ァチドから製造したものを用いることもできる。リゾフ
ォスファチジルコリンのアシル基は、リノール酸、オレ
イン酸、リルン酸、アラキドン酸、パルミチン酸、ミリ
スチン酸、ステアリン酸などから選ばれた1種又は2種
以上の混合物が適する。上記アシル基はグリセリンの1
位又は2位のいずれかに結合していてもよい。上記■リ
ゾフオスファチジルコリンは、実質的にモアシル体から
なるものが好ましいが、重量比で20%程度以内であれ
ばジアシル体のフォスフ1チジルコリン又は少量のコリ
ンフオスファチド以外のフォスファチドを含有してもよ
い。Lysophosphatidylcholine, which is one of the essential components of the composition of the present invention, can be obtained from natural products such as soybean phospholipids, rapeseed phospholipids, corn embryo phospholipids, and egg yolk phospholipids.
Phospholibase A-2 or Phospholibase A-
2 to form lysophospholipids, and the decomposition products are further fractionated by means such as fractionation with a solvent or column chromatography. In addition, it can be produced from any choline phosphatide that is chemically synthesized or produced by biological transesterification using various phospholipases (A, B, C, D). It is also possible to use a As the acyl group of lysophosphatidylcholine, one type or a mixture of two or more types selected from linoleic acid, oleic acid, lylunic acid, arachidonic acid, palmitic acid, myristic acid, stearic acid, etc. is suitable. The above acyl group is glycerin 1
It may be bonded to either the position or the 2nd position. The above (1) lysophosphatidylcholine preferably consists essentially of a moacyl form, but if the weight ratio is within about 20%, it may contain a diacyl form of phosphatidylcholine or a small amount of phosphatide other than choline phosphatide. You can.
上記■リゾフォスフフチジルコリン中のジアシル体のフ
ォスフ1チジルコリン及び他のフオスファチドの含量が
20%以上に増加すると、組成物全体の水中への可溶化
力が低下するので好ましくない。If the content of the diacyl phosph-1tidylcholine and other phosphatides in the above (1) lysophosphutidylcholine increases to 20% or more, the solubilizing power of the entire composition in water decreases, which is undesirable.
また、本発明の組成物の必須の構成成分の一つである■
炭素原子数16〜22の不飽和脂肪酸のモノグリセリド
としては、構成脂肪酸が、パルミトレイン酸、オレイン
酸、リノール酸、リレイン酸、アラキドン酸、エイコサ
ペンクエン酸等の不飽和脂肪酸から選ばれた1種以上、
及びこれらの不飽和脂肪酸と飽和脂肪酸との混合物であ
って沃素価が50以上のものが好ましく、上記範囲にあ
る、植物油及び/又は動物油起源のものが用いられる。In addition, one of the essential components of the composition of the present invention is
As a monoglyceride of an unsaturated fatty acid having 16 to 22 carbon atoms, the constituent fatty acid is one selected from unsaturated fatty acids such as palmitoleic acid, oleic acid, linoleic acid, ryleic acid, arachidonic acid, and eicosapencitric acid. that's all,
A mixture of these unsaturated fatty acids and saturated fatty acids with an iodine value of 50 or more is preferred, and those derived from vegetable oil and/or animal oil within the above range are used.
また、上記■不飽和脂肪酸モノグリセリドとしでは、モ
ノエステル含量が70%以上のものが好ましく、蒸溜モ
ノグリセリドの如き高純度品が適する。更に不飽和脂肪
酸の結合位置はグリセリンの1位、2位及び3位のいず
れであってもよい。Further, as for the unsaturated fatty acid monoglyceride mentioned above, one having a monoester content of 70% or more is preferable, and a highly purified product such as distilled monoglyceride is suitable. Furthermore, the bonding position of the unsaturated fatty acid may be any of the 1st, 2nd, and 3rd positions of glycerin.
上記■不飽和脂肪酸モノグリセリドを構成する脂肪酸の
飽和度が増加すると、組成物全体の水中の溶解性が低下
するので好ましくない。不飽和脂肪酸では炭素原子数1
5以下及び23以上のものは自然界に稀である。If the degree of saturation of the fatty acids constituting the unsaturated fatty acid monoglyceride increases, the solubility of the entire composition in water decreases, which is undesirable. Unsaturated fatty acids have 1 carbon atom
Those below 5 and above 23 are rare in nature.
また、本発明の組成物の必須の構成成分の一つである■
炭素原子数9〜13の脂肪酸としては、ラウリン酸、カ
プリン酸等が挙げられる。炭素原子数8以下及び14以
上のものでは本発明の主な目的である浸透力及び展着力
の優れた強い界面活性が得られない。In addition, one of the essential components of the composition of the present invention is
Examples of fatty acids having 9 to 13 carbon atoms include lauric acid and capric acid. If the number of carbon atoms is 8 or less or 14 or more, strong surface activity with excellent penetration and spreading power, which is the main objective of the present invention, cannot be obtained.
本発明の組成物は、前記■リゾフォスファチジルコリン
を純品に換算した量と前記■不飽和脂肪酸モノグリセリ
ドと前記■脂肪酸の3者間の含有割合が重量比で
■/■= 10/90〜90/10
■/■=20/100〜200/100■/(■+■)
−10/100〜200/100好ましくは、
■/■−20/80〜80/20
■/■−40/100〜150/100■/(■+■)
=25/100〜140/100である。In the composition of the present invention, the content ratio between the above-mentioned (1) lysophosphatidylcholine converted into a pure product, the above-mentioned (1) unsaturated fatty acid monoglyceride, and the above-mentioned (3) fatty acid is in a weight ratio of ■/■ = 10/90. ~90/10 ■/■=20/100~200/100■/(■+■)
-10/100~200/100 preferably, ■/■-20/80~80/20 ■/■-40/100~150/100■/(■+■)
=25/100 to 140/100.
前記■リゾフォスファチジルコリン(純品換算量)に対
する前記■不飽和脂肪酸モノグリセリドの重量比(■/
■)が10/90未満であると本発明の効果は不十分で
あり、90/10超であると組成物の水溶性が低下する
ので好ましくない。The weight ratio (■/
If the ratio (2) is less than 10/90, the effect of the present invention is insufficient, and if it exceeds 90/10, the water solubility of the composition decreases, which is not preferred.
また、前記■不飽和脂肪酸モノグリセリドに対する前記
■脂肪酸の重量比(■/■)が20/100未満である
と本発明の効果は不十分であり、200/100超であ
ると界面活性性の効果が増加しないばかりでなく、組成
物の水溶性が低下するために好ましくない、また、前記
■リゾフォスファチジルコリンと前記■不飽和脂肪酸モ
ノグリセリドの合計に対する前記■脂肪酸の重量比(■
/(■十〇)〕が10/l O0未満であると本発明の
効果は不十分であり、また200/100超であると界
面活性の効果の向上がないばかりか、組成物の水溶性が
悪化するので好ましくない、・本発明の組成物には、■
胆汁酸類及び/又は胆汁酸のアルカリ塩類を更に添加さ
せ得る。特に前記■、■及び■の各成分組成において、
(■十■)/■が概略で5を超える場合は、■胆汁酸類
及び/又は胆汁酸のアルカリ塩MIC以下、単に胆汁酸
という)の添加が必要となる。Furthermore, if the weight ratio (■/■) of the above-mentioned (■) fatty acid to the above-mentioned (1) unsaturated fatty acid monoglyceride is less than 20/100, the effect of the present invention will be insufficient, and if it exceeds 200/100, the surfactant effect will be reduced. Not only does it not increase, but also the water solubility of the composition decreases, which is undesirable.
/(■10)] is less than 10/l O0, the effect of the present invention will be insufficient, and if it exceeds 200/100, not only will the surfactant effect not be improved, but the water solubility of the composition will be reduced.・The composition of the present invention contains ■
Bile acids and/or alkali salts of bile acids may further be added. In particular, in each component composition of (1), (2) and (2) above,
When (■10■)/■ exceeds approximately 5, it is necessary to add (2) bile acids and/or alkali salts of bile acids (hereinafter MIC, simply referred to as bile acids).
上記■胆汁酸類としては、哺乳類の胆汁酸であればよく
、例えばコール酸、デオキシコール酸、ケノデオキシコ
ール酸及びリトコール酸等の胆汁酸から選ばれた1種又
は2種以上の混合物、特に好ましくはこれらの胆汁酸に
タウリン及び/又はグリシンを反応させた抱合胆汁酸、
或いはこれらの胆汁酸類のアルカリ金属塩が挙げられる
。上記■胆汁酸類の添加量は、前記■リゾフォスファチ
ジルコリン、前記■不飽和脂肪酸モノグリセリド及び前
記■脂肪酸の合計重量の5〜100%が通ずる。5%未
満では組成物の可溶化効果がなく、また100%以上加
えても可溶性状態は向上しないのでそれ以上添加する必
要がない、上記■胆ン1酸類の適量は、上記範囲内にお
いて、組成物の配合及び胆汁酸類の種類により適宜決定
される。The above-mentioned bile acids may be any mammalian bile acids; for example, one or a mixture of two or more bile acids selected from bile acids such as cholic acid, deoxycholic acid, chenodeoxycholic acid, and lithocholic acid, particularly preferably these. Conjugated bile acid obtained by reacting bile acid with taurine and/or glycine,
Alternatively, alkali metal salts of these bile acids may be mentioned. The amount of (1) bile acids added is 5 to 100% of the total weight of (1) lysophosphatidylcholine, (2) unsaturated fatty acid monoglyceride, and (2) fatty acid. If it is less than 5%, there is no solubilizing effect on the composition, and even if it is added more than 100%, the solubility state will not improve, so there is no need to add any more. It is determined as appropriate depending on the composition of the product and the type of bile acids.
本発明の組成物は、例えば以下の如(して製造すること
ができる。The composition of the present invention can be produced, for example, as follows.
(1)不飽和脂肪酸モノグリセリド及び脂肪酸の量が相
対的に多い場合は、それらとリゾフォスファチジルコリ
ン及び更に胆汁酸を用いる場合にはそれを共に加えて加
熱相溶することによって、粘稠な油状ペーストとして本
発明の組成物を得る。(1) If the amounts of unsaturated fatty acid monoglycerides and fatty acids are relatively large, they can be mixed with lysophosphatidylcholine, and if bile acids are used, they can be added together and heated to make them compatible. The composition of the invention is obtained as an oily paste.
(2)リゾフォスファチジルコリンの量が相対的に多い
場合及び不飽和脂肪酸モノグリセリドとりゾフォスフ1
チジルコリンの合計量が相対的に多い場合は、必要に応
じ胆汁酸類等を加えて、水溶性の良い順に各成分を水に
溶解しそのままこれを組成物とすることができる。また
、単に各成分を水に加えて加温し、超音波等を用いて水
性コロイド液とするか、回転羽根をもつミキサーや加圧
式のホモナイザー等によって水溶液としての組成物を得
ることができる。また更に、減圧下でこれらの水溶液か
ら水を除いて水性ペーストとしての組成物を得ることも
できる。(2) When the amount of lysophosphatidylcholine is relatively large and unsaturated fatty acid monoglyceride is added to zophosph 1
When the total amount of tidylcholine is relatively large, bile acids or the like may be added as necessary, and each component may be dissolved in water in order of water solubility, and this may be used as a composition as it is. Alternatively, the composition can be obtained by simply adding each component to water and heating it to form an aqueous colloidal solution using ultrasonic waves or the like, or by using a mixer with rotating blades, a pressurized homogenizer, or the like to obtain the composition as an aqueous solution. Furthermore, water can be removed from these aqueous solutions under reduced pressure to obtain a composition as an aqueous paste.
(3)本発明の組成物を簡単に得るには、各成分をヘキ
サン、エタノール、エーテル等の混合溶液に加え加力溶
解した後、減圧下で溶媒を除去してペースト状の組成物
となす方法がある。(3) To easily obtain the composition of the present invention, each component is added to a mixed solution of hexane, ethanol, ether, etc. and dissolved under pressure, and then the solvent is removed under reduced pressure to form a paste composition. There is a way.
本発明の組成物は、目的を損なわない範囲で他の界面活
性剤を含有することができるが、他の界面活性剤はかえ
って本発明の組成物の効果を損なう場合があるので注意
が必要である。The composition of the present invention may contain other surfactants as long as they do not impair the purpose; however, care must be taken as other surfactants may impair the effects of the composition of the present invention. be.
本発明の組成物の第4の成分である前記■胆汁酸類は、
それ自体界面活性の向上にさほどの影響を与えないが、
組成物の可溶化に役立つ。また、胆汁酸塩の添加によっ
て組成物水溶液の表面張力低下能はやや減少する傾向が
あり、接触角には殆ど影響はなく、浸透力は若干向上す
る傾向がある。The fourth component of the composition of the present invention is the above-mentioned bile acids,
Although it does not have much effect on improving surface activity in itself,
Helps solubilize the composition. Furthermore, the addition of bile salts tends to slightly reduce the surface tension lowering ability of the aqueous composition solution, has little effect on the contact angle, and tends to slightly improve the penetrating power.
本発明の組成物の構成成分である前記■リゾフォスファ
チジルコリン、前記■不飽和脂肪酸モノグリセリド及び
前記■脂肪酸の中で、水溶性を有し従って浸透・湿潤作
用を有するものはりゾフォスファチジルコリンのみであ
り、他の2成分は実質的に水に不溶であるが、前者によ
って後2者が可溶化される。Among the above-mentioned (1) lysophosphatidylcholine, (1) unsaturated fatty acid monoglyceride, and (1) fatty acid which are the constituent components of the composition of the present invention, the one which is water-soluble and has penetrating and moisturizing effects is zophosphatidyl. Although only choline and the other two components are substantially insoluble in water, the former solubilizes the latter two.
本発明の組成物を水に溶解したミセル溶液は、強い浸透
作用及び湿潤作用等の界面活性等を示す。A micellar solution prepared by dissolving the composition of the present invention in water exhibits surface activities such as strong penetrating action and wetting action.
リゾフォスファチジルコリンと不飽和脂肪酸モノグリセ
リド及び/又は飽和脂肪酸モノグリセリドの二成分から
なる組成物には、リゾフォスファチジルコリン自体が組
成物と同一濃度で示す浸透・湿潤作用以上の改善はない
か、或いはあっても僅かである。しかし、本発明の組成
物のように炭素原子数9〜13の中鎖脂肪酸がこの系に
加わると、上記界面活性は飛躍的に高まる。Does a composition consisting of two components, lysophosphatidylcholine and unsaturated fatty acid monoglyceride and/or saturated fatty acid monoglyceride, have an improvement in the penetration and moisturizing effect beyond that exhibited by lysophosphatidylcholine itself at the same concentration as the composition? , or at least very little. However, when a medium chain fatty acid having 9 to 13 carbon atoms is added to this system as in the composition of the present invention, the above-mentioned surface activity increases dramatically.
本発明の組成物は、掘めて安全で且つ強い界面活性能を
有し浸透剤、湿潤剤、展着剤として使用できる他に、不
溶性の微粒子様の分散剤、水中油型乳化剤、油中水型乳
化剤、油相中への親水性物質の可溶化剤、水相中への親
油性物質の可溶化剤としても使用できる。The composition of the present invention is safe to dig, has strong surfactant ability, and can be used as a penetrating agent, a wetting agent, and a spreading agent. It can also be used as an aqueous emulsifier, a solubilizer for hydrophilic substances in an oil phase, and a solubilizer for lipophilic substances in an aqueous phase.
即ち、具体的には、これらの特性を活かし、浸透・湿潤
剤として、粉体の食品、飼料、化粧品、医薬品等の湿潤
性の改良、毛髪等のリンス剤、植物体や昆虫への薬品類
の展着剤、紙や布等の繊維製品等の濡れの改良等に用い
る事ができる0例えば、食用油脂、植物精油、パラフィ
ン類及びその他の油性物質の水中油型及び油中水型の乳
化、ココアパウダー、インスタント食品粉末、香辛料粉
末、バラオキシ安息香酸ブチル等の防黴剤及び各種顔料
粉末等の分散化、水中への湿潤や易分散化、成る程度の
酸性下での上記の物質の乳化ないし分散化、油脂中への
不溶物質の可溶化等への利用が挙げられる。Specifically, by taking advantage of these properties, it can be used as a penetrating/wetting agent to improve the wettability of powdered foods, feeds, cosmetics, pharmaceuticals, etc., as a hair rinse agent, and as chemicals for plants and insects. For example, oil-in-water and water-in-oil emulsification of edible oils, vegetable essential oils, paraffins, and other oily substances. , dispersion of cocoa powder, instant food powder, spice powder, antifungal agents such as butyl roseoxybenzoate, various pigment powders, etc., wetting and dispersion in water, and emulsification of the above substances under acidic conditions to the extent necessary. Examples include use for dispersion, solubilization of insoluble substances in fats and oils, etc.
また、本発明の組成物は、動植物体の細胞膜等から酵素
等の蛋白質を溶脱する。この分野では強力な界面活性剤
としてポリオキシエチレンノニルフェノールエーテルが
多用されているが、この界面活性剤は一部の蛋白質を変
性させる場合がある。Furthermore, the composition of the present invention leaches proteins such as enzymes from cell membranes of animals and plants. In this field, polyoxyethylene nonylphenol ether is often used as a strong surfactant, but this surfactant may denature some proteins.
また、この目的にはリソ゛フォスファチジJレコリンを
用いることができるが、その効力は必ずしも十分でない
、これに対し、本発明の組成物は、安全且つ強力である
。Although lysophosphatide J. lecorin can also be used for this purpose, its efficacy is not always sufficient; on the other hand, the composition of the present invention is safe and potent.
果に、本発明の組成物の重要な用途としては、その高度
の浸透性を活用して、経腸、経皮及び経粘膜による薬剤
の吸収を促進するために有効であると共に、本発明の組
成物自体に生理活性を有するエイコサペンタエン酸、T
−リルン酸等の多不飽和脂肪酸、ペンタデカン酸の様な
奇数酸を組み込むことによって本発明の組成物自体を薬
剤として用いることもできる。また、本発明の組成物は
、油脂乳化液に使用し、他の栄養素と併用して5消化性
の経腸栄養剤として用いることができる。In fact, an important use of the composition of the present invention is that it is effective to utilize its high permeability to promote the absorption of drugs through the enteral, transdermal, and transmucosal routes. Eicosapentaenoic acid, T, which has physiological activity in the composition itself
- The composition of the present invention itself can also be used as a drug by incorporating polyunsaturated fatty acids such as lylunic acid, odd-numbered acids such as pentadecanoic acid. Furthermore, the composition of the present invention can be used in an oil-fat emulsion and used in combination with other nutrients as a 5-digestible enteral nutrient.
薬剤吸収の促進は単に哺乳動物のみならず、広く昆虫等
の動物、農作物等の植物にも応用することができる。Promotion of drug absorption can be applied not only to mammals but also to a wide range of animals such as insects and plants such as agricultural crops.
尚、本発明の組成物は、水中及び油脂等の非極性溶媒中
のいずれにもミセルを作って溶解しやすい両親媒性を示
す。The composition of the present invention exhibits amphipathic properties that allow it to easily form micelles and dissolve in both water and non-polar solvents such as oils and fats.
〔実施例]
以下に本発明の実施例を挙げ、本発明を更に詳しく説明
するが、本発明は下記の実施例に制限されるものではな
い。[Example] The present invention will be described in more detail by referring to Examples below, but the present invention is not limited to the following Examples.
面、実施例中「%」及び「部」は特に断ら、ない限り「
重量%」及び1重量部」を意味するものである。"%" and "part" in the examples are "%" and "part" unless otherwise specified.
% by weight" and 1 part by weight".
実施例1
市販大豆燐脂質をアセトンで脱脂し、これに含水アルコ
ールによる分画を行ってフォスファチジルコリン70%
を含むフオスファチドを得た。このものにフ才スフォリ
バーゼA−2(ノボ社製レシターゼ1O−L)を作用さ
せた後、アセトン処理で脂肪酸を除き、更に含水アルコ
ール処理及び含水アルコールを用いたシリカゲルクロマ
ト処理を行い、リゾフオスファチジルコリン97%ヲ含
むフォスファチドを得た。リゾフォスファチジルコリン
としては、このフオスファチドを用いた。Example 1 Commercially available soybean phospholipids were defatted with acetone and fractionated with hydroalcohol to obtain 70% phosphatidylcholine.
We obtained phosphatide containing . After treating this product with lysopholibase A-2 (Recitase 1O-L, manufactured by Novo), fatty acids were removed by acetone treatment, and further treated with hydrous alcohol and silica gel chromatography using hydrous alcohol. A phosphatide containing 97% zircholine was obtained. This phosphatide was used as lysophosphatidylcholine.
また、不飽和脂肪酸モノグリセリドとしては、主として
リノール酸からなるモノグリセリド:理研ビタミン■製
エマルジーMU(リノール酸74%、オレイン酸13%
、パルミチン酸8%、ステアリン酸2.6%等を含み、
モノエステル含量95%、沃素化116)、同社製エマ
ルジーMO(リノール酸47%、オレイン酸14%、パ
ルミチン酸37%等を含み、モノエステル含!I93%
、沃素化72)、及び主としてオレイン酸のモノグリセ
リドとして同社製エマルジーOL(オレイン酸74%、
リノール酸5%、パルミトオレイン酸5%、バルミチン
酸4%、モノエステル含193%。In addition, as unsaturated fatty acid monoglycerides, monoglycerides mainly consisting of linoleic acid: Emulgy MU manufactured by Riken Vitamin ■ (74% linoleic acid, 13% oleic acid)
, 8% palmitic acid, 2.6% stearic acid, etc.
Monoester content: 95%, iodination: 116), Emulgy MO manufactured by the same company (contains linoleic acid: 47%, oleic acid: 14%, palmitic acid: 37%, etc., monoester content: I: 93%)
, iodinated 72), and the company's Emulgy OL (oleic acid 74%,
Contains 5% linoleic acid, 5% palmitoleic acid, 4% valmitic acid, and 193% monoester.
沃素化67)を用いた。Iodination67) was used.
また、脂肪酸としては、ラウリン酸として日本油脂■製
NAA−122(純度99%)、カプリン酸として■花
王製ルナツク10−95 (純度95%)を用いた。Further, as the fatty acids, lauric acid was used as NAA-122 (purity 99%) manufactured by NOF Corporation, and as capric acid, Lunatsuku 10-95 manufactured by Kao Corporation (purity 95%) was used.
また、胆汁酸塩類としては、デイフコ・ラボラトリ−製
タウロコール酸ナトリウム(純度70%)を用いた。As the bile salts, sodium taurocholate (purity 70%) manufactured by Difco Laboratories was used.
また、比較のために本発明の範囲外の組成物成分として
、日本油脂製のミリスチン酸、NAAI42(純度99
%)、花王■製のカプリル酸、ルナツク8−95 (純
度95%)を用いた。For comparison, as a composition component outside the scope of the present invention, myristic acid, NAAI42 (purity 99
%), caprylic acid manufactured by Kao ■, Lunatsuk 8-95 (purity 95%) was used.
下記表−1に示す各配合物を、全重量の3倍量のヘキサ
ンアルコール(1: 1)混合液に加えて加温し相溶さ
せ、減圧下で溶媒を除去して組成物をそれぞれ得た。Each of the formulations shown in Table 1 below was added to a mixture of hexane alcohol (1:1) in an amount three times the total weight, heated to make them compatible, and the solvent was removed under reduced pressure to obtain each composition. Ta.
各組成物からタウロコール酸ナトリウムを除く部分の濃
度が0.2%の水溶液を作り、下記の各種の界面活性試
験を行った。An aqueous solution having a concentration of 0.2% for the portion excluding sodium taurocholate from each composition was prepared, and various surface activity tests described below were conducted.
(1)表面張力低下能:協和科学■型表面張力系CBV
P−A−3型に白金プレート片を付して35℃における
表面張力を測定した。(1) Surface tension reducing ability: Kyowa Science ■ type surface tension system CBV
A platinum plate piece was attached to Model PA-3, and the surface tension at 35°C was measured.
(2)キャンパスディスク沈降法:直径1インチの厚手
のキャンパス布を用い「産業図書■界面活性剤便覧、1
960年、J860頁記載の方法による浸透力を37°
C及び25°Cで測定した。(2) Campus disk sedimentation method: Using a thick campus cloth with a diameter of 1 inch, “Industrial Book ■ Surfactant Handbook, 1
960, the penetration power was 37° by the method described on page J860.
Measured at 25°C and 25°C.
(3)接触角測定:■エルマー社製接触角測定器(エル
マー13型)によって30″Cにおける蜜蝋及び木蝋に
対する接触角を測定した。(3) Contact angle measurement: ■ The contact angles for beeswax and wooden wax at 30''C were measured using a contact angle measuring device manufactured by Elmer (Elmer 13 model).
(4)植物葉面への展着試験;胆汁酸類を除く部分の濃
度が0.1容量%の組成物、キサンタンガム(メルク社
製、エコーガム)0.06容量%、及び食用色素青色1
号(ブリリアントブルーFCF、三栄化学工業製)少量
を含む各水溶液(展着液)を用いて次のようにして展着
試験を行った。(4) Spreading test on plant leaves; composition with a concentration of 0.1% by volume excluding bile acids, 0.06% by volume of xanthan gum (Merck & Co., Ltd., Echo Gum), and food coloring blue 1
A spreading test was carried out as follows using each aqueous solution (spreading liquid) containing a small amount of No. Brilliant Blue FCF (manufactured by Sanei Chemical Industry Co., Ltd.).
キャベツの外側から6〜8枚目の葉の葉柄以外の部分で
lOx6cmのテスト片を作り、25°Cの展着液30
MにlO秒間浸した後、濾紙上で乾燥し、青色色素の展
着状態を観察した。Make a test piece of 1O x 6cm from the part other than the petiole of the 6th to 8th leaf from the outside of the cabbage, and add 30cm of spreading solution at 25°C.
After being immersed in M for 10 seconds, it was dried on a filter paper and the state of spread of the blue dye was observed.
評価は、葉面が90%以上青色に着色したもの5点、7
0〜90%のもの:4点、50〜70%のもの23点、
30〜50%のもの22点、10〜30%のもの11点
とした。Evaluation: 5 points, 7 points for plants with 90% or more of the leaf surface colored blue
0-90%: 4 points, 50-70%: 23 points,
There were 22 items with 30-50% and 11 items with 10-30%.
試験の結果は、下記表−1に示した。The test results are shown in Table 1 below.
(以下、余白)
実施例2
市販大豆燐脂質をアセトンで脱脂し、これに含水アルコ
ールによる分画を行ってフォスファチジルコリン70%
を含むフォスファチドを得た。このものにフォスフォリ
パーゼA−2(ノボ社製レシターゼ10L)を作用させ
た後、アセトン処理で脂肪酸を除き、更に含水アルコー
ル処理及び含水アルコールを用いたシリカゲルクロマト
処理を行い、リゾフォスファチジルコリン87%を含む
フォスファチドを得た。(Hereinafter, blank space) Example 2 Commercially available soybean phospholipids were defatted with acetone, and fractionated with hydrous alcohol to obtain 70% phosphatidylcholine.
A phosphatide containing the following was obtained. After treating this product with phospholipase A-2 (Recitase 10L manufactured by Novo), fatty acids were removed by acetone treatment, and further treated with hydrous alcohol and silica gel chromatography using hydrous alcohol. A phosphatide containing 87% was obtained.
このリゾフォスファチジルコリンを純分で17部、エマ
ルシーMU33部、ラウリン酸50部及びシグマ社製の
結晶グリココール酸20部を用い、実施例1と同様の方
法によって組成物を得た。この組成物のグリココール酸
を除く部分の濃度が0゜2%及び0.5%の水溶液を作
り、実施例1と同様の界面活性試験を行った。試験の結
果は次の通りであった。A composition was obtained in the same manner as in Example 1 using 17 parts of pure lysophosphatidylcholine, 33 parts of Emulcy MU, 50 parts of lauric acid, and 20 parts of crystalline glycocholic acid manufactured by Sigma. Aqueous solutions with concentrations of 0.2% and 0.5% of the portion of this composition excluding glycocholic acid were prepared, and the same surface activity test as in Example 1 was conducted. The results of the test were as follows.
0.2%水溶液の場合:
表面張力26.7 dyne/ cm、 37°Cでの
浸透時間27.3秒、蜜蝋に対する接触角35°、木蝋
に対する接触角41゜
0.5%水溶液の場合:
37°Cでの浸透時間6.7秒
実施例3
卵黄燐脂質(旭化成工業 ?#製卵黄レシチン)の水ペ
ーストに実施例1と同様の処理を行い、リゾフォスファ
チジルコリン98%を含むフォスファチドを得た。For 0.2% aqueous solution: Surface tension 26.7 dyne/cm, penetration time 27.3 seconds at 37°C, contact angle for beeswax 35°, contact angle for wax wax 41° For 0.5% aqueous solution: Penetration time at 37°C: 6.7 seconds Example 3 A water paste of egg yolk phospholipid (egg yolk lecithin manufactured by Asahi Kasei Industries, Ltd.) was treated in the same manner as in Example 1 to form a phosphatide containing 98% of lysophosphatidylcholine. I got it.
このフォスファチド17部、エマルシーMU33部、カ
プリン酸50部及びタウロコール酸ナトリウム30部を
配合し、実施例1と同様にして組成物を得た。この組成
物について実施例2と同様の界面活性試験を行った。試
験の結果は次の通りであった。A composition was obtained in the same manner as in Example 1 by blending 17 parts of this phosphatide, 33 parts of Emulcy MU, 50 parts of capric acid, and 30 parts of sodium taurocholate. A surface activity test similar to that in Example 2 was conducted on this composition. The results of the test were as follows.
表面張力27.2dyne/ca+、37°Cでの浸透
時間27.1秒、蜜蝋に対する接触角38°、木蝋に対
する接触角41”
実施例4
実施例3で用いた各成分の比率を変え、リゾフォスファ
チジルコリン/エマルジーMU/カプリン酸/タウロコ
ール酸ナトリウムを20 : 40 :40:40(重
量比)とした組成物について実施例3と同様の界面活性
試験を行った。試験の結果は次の通りであった。Surface tension: 27.2 dyne/ca+, penetration time at 37°C: 27.1 seconds, contact angle with beeswax: 38°, contact angle with wax: 41" Example 4 The ratio of each component used in Example 3 was changed, and the A surface activity test similar to that in Example 3 was conducted on a composition containing phosphatidylcholine/Emulgy MU/capric acid/sodium taurocholate in a weight ratio of 20:40:40:40.The test results are as follows. It was on the street.
表面張力27.8 dyne/c+w、 37 ”Cで
の浸透時間32.1秒、蜜蝋に対する接触角40°、木
蝋に対する接触角43゜
応用例1
実施例1−1及び1−2の組成物について、無機顔料チ
タンホワイトの分散試験、ココアの湿潤試験及びココア
の易分散化試験を行った。Surface tension: 27.8 dyne/c+w, penetration time at 37''C: 32.1 seconds, contact angle to beeswax: 40°, contact angle to wax: 43° Application Example 1 Regarding the compositions of Examples 1-1 and 1-2 , a dispersion test for the inorganic pigment titanium white, a wetting test for cocoa, and an easy dispersion test for cocoa.
〔無機顔料チタンホワイトの分散試験〕各組成物の0.
25%(W/Vol)水溶液を作り、この水溶液20d
と顔料用のチタンホワイト(帝国化工業型JR−701
)Igをネスラー管にとり、上下に激しく振盪して分散
させた後、室内に1日及び3日放置して粒子の沈降状態
を観察した。その結果を下記表−2に示した。[Dispersion test of inorganic pigment titanium white] 0.
Make a 25% (W/Vol) aqueous solution, and 20 d of this aqueous solution
and titanium white for pigments (Teikoku Kagyo type JR-701
) Ig was placed in a Nessler tube, shaken vigorously up and down to disperse it, and then left indoors for 1 and 3 days to observe the sedimentation state of the particles. The results are shown in Table 2 below.
表−2
単なる水中への分散では1時間後に殆ど完全に粒子が沈
降するが、本発明の組成物を用いた場合は、2日目以後
に粒子の沈降があっても大量の粉体が上部に残っている
。Table 2 When simply dispersing in water, the particles almost completely settle out after one hour, but when using the composition of the present invention, even if the particles settle after the second day, a large amount of the powder remains at the top. remains.
各組成物の胆汁酸類を除く部分の濃度が0.2%となる
様に水溶液を作り、ビーカーに100#dlあて分注す
る。各水溶液を20°Cとなしマグネチンクスターラー
上で上部にわずかに凹面ができる程度の一定速度の撹拌
を行いながら、1gのココア粉末(不二家■製、バーシ
ーココア)を水面上に浮かべ粉末が実質的に水中に分散
するまでの時間を測定した。各組成物での試験結果(3
例の平均)を下記表−3に示したが、ココアのぬれの促
進が認められた。An aqueous solution is prepared so that the concentration of the part of each composition excluding bile acids is 0.2%, and the solution is dispensed into a beaker using 100 #dl. While each aqueous solution was heated to 20°C and stirred at a constant speed on a magnetic stirrer to form a slightly concave surface on the top, 1 g of cocoa powder (Fujiya Co., Ltd., Versi Cocoa) was floated on the water surface until the powder was completely absorbed. The time required for the particles to disperse in water was measured. Test results for each composition (3
The average of the examples is shown in Table 3 below, and promotion of cocoa wetting was observed.
表−3
(ココアの易分散化試験)
実施例1−1の組成物3gをエチルアルコール40gに
溶解し、これとココア粉末(不二家a勾製、バーシーコ
コア)147gをケンランドミキサー中で冷却しつつよ
く撹拌混合し均一にする0次いで、減圧下にアルコール
を除いて乾燥し、混合物を乳鉢中で粉砕し、インスタン
トココア■を得た。Table 3 (Cocoa dispersibility test) 3 g of the composition of Example 1-1 was dissolved in 40 g of ethyl alcohol, and this and 147 g of cocoa powder (Fujiya A-Ko, Versi Cocoa) were cooled in a Kenland mixer. The mixture was thoroughly stirred and mixed to make it homogeneous.Then, the alcohol was removed under reduced pressure and the mixture was dried, and the mixture was ground in a mortar to obtain instant cocoa (2).
また、リツウトウエステルS−1670−3を用いて同
様にしてインスタントココア■を得た。In addition, instant cocoa (2) was obtained in the same manner using Ritsuto Wester S-1670-3.
これらのインスタントココア■及び■それぞれ2gを、
20°Cの水50m1を入れた50m1容ビーカーの水
面におだやかに移し、インスタントココアの全量が実質
的に水面から沈む時間を測定した。2g each of these instant cocoa ■ and ■,
The instant cocoa was gently transferred to the surface of a 50 ml beaker containing 50 ml of water at 20° C., and the time required for substantially all of the instant cocoa to submerge from the water surface was measured.
同一サンプルについて4回測定しそれらの平均値をとっ
た。その結果は次の通りである。また、本発明の組成物
を用いたインスタントココアは・冷水中に加えると撹拌
により容易に良好な分n41.を示した。The same sample was measured four times and the average value was taken. The results are as follows. Moreover, the instant cocoa using the composition of the present invention can be easily obtained by stirring when added to cold water. showed that.
インスタントココア■ 2分20秒
インスタントココア■ 7分02秒
〔本発明の効果〕
本発明の組成物は、極めて安全性が高く、かつ高度の浸
透性、湿潤性及び展着性等の界面活性作用を有する脂質
系の組成物である。Instant cocoa ■ 2 minutes 20 seconds Instant cocoa ■ 7 minutes 02 seconds [Effects of the present invention] The composition of the present invention is extremely safe and has surface active effects such as high permeability, wettability, and spreadability. It is a lipid-based composition having the following properties.
即ち、本発明の組成物は、
■すべて天然の脂質によって構成されるためにそれらの
水溶液は生体の内皮、外皮に投与すれば血中や細胞中に
投与しないかぎり、生体に対する作用は温和で安全であ
る上、
■高度の浸透・湿潤作用を有し、
■動植物の表面によく展着し、
■微小な固体粒子の水中分散を良好となし、■油性物質
の乳化にも有効に用いられる等の優れた界面活性能を有
する。That is, the composition of the present invention is composed of all natural lipids; therefore, if an aqueous solution thereof is administered to the endothelium or outer skin of a living body, its effect on the living body is mild and safe unless it is administered into the blood or cells. In addition, ■It has a high degree of penetrating and moisturizing effect, ■It spreads well on the surfaces of animals and plants, ■It allows for good dispersion of minute solid particles in water, and ■It is also used effectively for emulsifying oil-based substances. It has excellent surfactant ability.
Claims (1)
セリド、及び (3)炭素原子数9〜13の脂肪酸を含有し、上記成分
(1)〜(3)の割合(重量比)は、(2)/(1)=
10/90〜90/10 (3)/(2)=20/100〜200/100 (3)/((1)+(2))=10/100〜200/
100であり、かつ ((2)+(3))/(1)が5を超える場合は、 (4)胆汁酸類及び/又は胆汁酸のアルカリ塩類を、成
分((1)+(2)+(3))の重量の5〜100%含
有する ことを特徴とする安全でかつ高度な界面活性を有する脂
質組成物。[Scope of Claims] As essential constituents, (1) lysophosphatidylcholine, (2) monoglycerides of unsaturated fatty acids having 16 to 22 carbon atoms, and (3) fatty acids having 9 to 13 carbon atoms. The ratio (weight ratio) of the above components (1) to (3) is (2)/(1)=
10/90~90/10 (3)/(2)=20/100~200/100 (3)/((1)+(2))=10/100~200/
100 and ((2)+(3))/(1) exceeds 5, (4) Bile acids and/or alkali salts of bile acids are added to the component ((1)+(2)+ (3) A lipid composition that is safe and has a high degree of surface activity, characterized by containing 5 to 100% of the weight of (3)).
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63138151A JPH01307438A (en) | 1988-06-04 | 1988-06-04 | Safe lipid composition having high surface activity |
DE68916630T DE68916630T2 (en) | 1988-04-28 | 1989-04-24 | LIPID COMPOSITION WITH SUFFICIENT SAFETY AND STRONG SURFACE EFFECT. |
AT89905208T ATE108091T1 (en) | 1988-04-28 | 1989-04-24 | LIPID COMPOSITION WITH SUFFICIENT SAFETY AND STRONG SURFACE ACTION. |
PCT/JP1989/000430 WO1989010186A1 (en) | 1988-04-28 | 1989-04-24 | Lipid composition having enough safety and strong surface activity |
EP89905208A EP0375785B1 (en) | 1988-04-28 | 1989-04-24 | Lipid composition having enough safety and strong surface activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63138151A JPH01307438A (en) | 1988-06-04 | 1988-06-04 | Safe lipid composition having high surface activity |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01307438A true JPH01307438A (en) | 1989-12-12 |
Family
ID=15215210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63138151A Pending JPH01307438A (en) | 1988-04-28 | 1988-06-04 | Safe lipid composition having high surface activity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01307438A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0556751A (en) * | 1991-08-31 | 1993-03-09 | Q P Corp | Protein composite material |
-
1988
- 1988-06-04 JP JP63138151A patent/JPH01307438A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0556751A (en) * | 1991-08-31 | 1993-03-09 | Q P Corp | Protein composite material |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100193980B1 (en) | Oil-in-water emulsion | |
JP2643217B2 (en) | Aqueous liquid of fat-soluble substance | |
AU691250B2 (en) | Lipophilic carrier preparations | |
JPH0347527A (en) | Method for producing nano-emulsion of oil particle in water phase, manufacture of pharmaceutical and cosmetic agent, and manufacture of nutrition solution for cellculture | |
JP7496152B2 (en) | Retinal-containing multilamellar vesicles and cosmetic compositions containing the same | |
EP0084341B1 (en) | Emulsion-type composition for external use | |
BR112014028180B1 (en) | EMULSION, DIETARY SUPPLEMENT, AND USE OF AN EMULSION | |
JPH01274830A (en) | Safe lipid composition having high surface activity | |
JP7211818B2 (en) | Skin topical agent | |
AU764413B2 (en) | A pharmaceutical composition comprising cyclosporin in a lipid carrier | |
JPS61204109A (en) | Emulsion-type composition for external use | |
JPH01307438A (en) | Safe lipid composition having high surface activity | |
US20130295182A1 (en) | Liquid crystalline phytosterol-glycerine complex for enhanced bioavailability and water dispersal | |
DE68926162T2 (en) | Glycerophospholipid preparation with increased wetting effect | |
JP2514995B2 (en) | Composition for promoting absorption of substance by transdermal and transmucosal | |
JP6411050B2 (en) | Liposomes and cosmetics containing the same | |
DE68916630T2 (en) | LIPID COMPOSITION WITH SUFFICIENT SAFETY AND STRONG SURFACE EFFECT. | |
Flores-Villaseñor et al. | Biocompatible microemulsions for the nanoencapsulation of essential oils and nutraceuticals | |
WO2003020318A1 (en) | A topical w/o-emulsion composition | |
JPS62221629A (en) | Production of phospholipid emulsion | |
JPS60192546A (en) | Edible liquid compounded oil | |
RU2127124C1 (en) | Lipophilic carrier preparations | |
JPH01307437A (en) | Safe lipid composition having high surface activity | |
SE518823C2 (en) | Oil-in-water emulsions | |
RU2623210C1 (en) | Liquid crystalline composition for transdermal delivery of biologically active substances |